Health Care·Life Sciences Tools & Services·$174.6B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.97 | N/A | -29.42% |
management commentary, guidance changes, and full analysis available with Pro.
| -29.42% |
Tone: Defensive
Management acknowledged the difficulties faced during the quarter. They emphasized the importance of operational efficiency in the current environment.
We are navigating through challenging market conditions.
Our focus remains on maintaining operational efficiency.
Thermo Fisher Scientific reported an EPS that fell short of expectations, leading to a significant surprise. Despite this, the stock rose by 5%, likely driven by investor optimism about the company's resilience in challenging times. The lack of guidance may leave some investors cautious as they assess future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
INFOSYS LTD ADR
Apr 20, 2020